Optimizing Glucagon for Medical Use: Better Diabetes and Obesity Drug Candidates
Systematic optimization of the native glucagon sequence produced analogs with improved stability, selectivity, and pharmacokinetics for potential dual GLP-1/glucagon receptor agonist obesity and diabetes drugs.
Quick Facts
What This Study Found
Systematic optimization of the native glucagon sequence produced analogs with improved stability, selectivity, and pharmacokinetics for potential dual GLP-1/glucagon receptor agonist obesity and diabetes drugs.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding Systematic optimization of the native glucagon sequence produced analogs with improved stability, selectivity, and pharmacokinetics for potential dual
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2010.
- Original Title:
- Optimization of the native glucagon sequence for medicinal purposes.
- Published In:
- Journal of diabetes science and technology, 4(6), 1322-31 (2010)
- Database ID:
- RPEP-01596
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Optimizing Glucagon for Medical Use: Better Diabetes and Obesity Drug Candidates
What was found?
Systematic optimization of the native glucagon sequence produced analogs with improved stability, selectivity, and pharmacokinetics for potential dual GLP-1/glucagon receptor agonist obesity and diabetes drugs.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01596APA
Chabenne, Joseph R; DiMarchi, Maria A; Gelfanov, Vasily M; DiMarchi, Richard D. (2010). Optimization of the native glucagon sequence for medicinal purposes.. Journal of diabetes science and technology, 4(6), 1322-31.
MLA
Chabenne, Joseph R, et al. "Optimization of the native glucagon sequence for medicinal purposes.." Journal of diabetes science and technology, 2010.
RethinkPeptides
RethinkPeptides Research Database. "Optimization of the native glucagon sequence for medicinal p..." RPEP-01596. Retrieved from https://rethinkpeptides.com/research/chabenne-2010-optimization-of-the-native
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.